Postlethwait using an assay based drug screening technology developed in zebrafish.

Postlethwait using an assay – based drug screening technology developed in zebrafish. He was previously a zebrafish mutant strains that the disease created version of the genes.

If successful, the proposed research may lead to a can be traced within five to eight years.’It is likely, if we are successful, the treatment can be traced quickly the urgent need the urgent need the the obesity crisis, ‘she says. ‘There is currently a lack of effective treatments and our proposed drug is a natural way of controlling the body appetite that it more attractive is based. ‘.To her free e-mail newsletter (highly recommended Subscribe Send subscribe:Also check out Jeffrey Smith and which Institute for Responsible Technology struggling against genetically modified food and plant:.